Literature DB >> 12165660

Pituitary adenoma with "honeycomb Golgi" appearance showing a phenotypic change at recurrence from clinically nonfunctioning to typical Cushing disease.

Toshiaki Sano1, Kalman Kovacs, Sylvia L Asa, Shozo Yamada, Naoko Sanno, Shunichi Yokoyama, Hiroshi Takami.   

Abstract

An adenoma resected from a 49-yr-old woman was clinically nonfunctioning but immunopositive for adrenocorticotropic hormone (ACTH) in a few cells. Electron microscopy demonstrated a vacuolar change in Golgi complexes known as "honeycomb Golgi." Recurrent adenoma resected 11 mo later was positive for ACTH in more cells than in the initial one. Two months later the patient presented with typical signs and symptoms of Cushing disease with elevated blood cortisol and ACTH levels and was treated by gamma knife radiotherapy. Among adenomas that are initially clinically silent but became functionally active with recurrence, corticotroph adenomas seem to be the most frequent. Study of transcription factors will be helpful to clarify whether adenomas with honeycomb Golgi represent exclusively gonadotroph adenomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165660     DOI: 10.1385/ep:13:2:125

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  10 in total

1.  Clinico-pathological study of Cushing's disease with large pituitary adenoma.

Authors:  H Ikeda; T Yoshimoto; Y Ogawa; K Mizoi; O Murakami
Journal:  Clin Endocrinol (Oxf)       Date:  1997-06       Impact factor: 3.478

2.  The silent corticotropinoma: is clinical diagnosis possible?

Authors:  B Ambrosi; P Colombo; D Bochicchio; M Bassetti; B Masini; G Faglia
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

3.  The development of Cushing's syndrome from a previously silent pituitary tumour.

Authors:  M E Cooper; R M Murray; R Kalnins; J Woodward; G Jerums
Journal:  Aust N Z J Med       Date:  1987-04

4.  Pituitary Cushing's disease arising from a previously non-functional corticotrophic chromophobe adenoma.

Authors:  N J Vaughan; C M Laroche; I Goodman; M J Davies; J S Jenkins
Journal:  Clin Endocrinol (Oxf)       Date:  1985-02       Impact factor: 3.478

5.  Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission.

Authors:  E L Gogel; P R Salber; J B Tyrrell; M L Rosenblum; J W Findling
Journal:  Arch Intern Med       Date:  1983-05

6.  A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins.

Authors:  B Lamolet; A M Pulichino; T Lamonerie; Y Gauthier; T Brue; A Enjalbert; J Drouin
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

7.  Sex-linked ultrastructural dichotomy of gonadotroph adenomas of the human pituitary: an electron microscopic analysis of 145 tumors.

Authors:  G Kontogeorgos; E Horvath; K Kovacs
Journal:  Ultrastruct Pathol       Date:  1990 Nov-Dec       Impact factor: 1.094

8.  Gonadotroph adenomas of the human pituitary: sex-related fine-structural dichotomy. A histologic, immunocytochemical, and electron-microscopic study of 30 tumors.

Authors:  E Horvath; K Kovacs
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

9.  Changes in the immunophenotype of recurrent pituitary adenomas.

Authors:  T Mindermann; K Kovacs; C B Wilson
Journal:  Neurosurgery       Date:  1994-07       Impact factor: 4.654

10.  Cushing's disease due to female gonadotroph adenoma of the pituitary.

Authors:  H Ikeda; T Yoshimoto; K Kovacs; E Horvath
Journal:  Clin Endocrinol (Oxf)       Date:  1995-09       Impact factor: 3.478

  10 in total
  13 in total

1.  Difficult cases of thyroid pathology.

Authors:  Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 2.  Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

Authors:  Odelia Cooper; Shlomo Melmed
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

3.  The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3.

Authors:  Alberto Righi; Marco Faustini-Fustini; Luca Morandi; Valentina Monti; Sofia Asioli; Diego Mazzatenta; Antonella Bacci; Maria Pia Foschini
Journal:  Endocrine       Date:  2016-08-04       Impact factor: 3.633

Review 4.  Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.

Authors:  Fabienne Langlois; Dawn Shao Ting Lim; Chris G Yedinak; Isabelle Cetas; Shirley McCartney; Justin Cetas; Aclan Dogan; Maria Fleseriu
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

Review 5.  Silent corticotroph adenomas.

Authors:  Odelia Cooper
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

6.  Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.

Authors:  Odelia Cooper; Anat Ben-Shlomo; Vivien Bonert; Serguei Bannykh; James Mirocha; Shlomo Melmed
Journal:  Horm Cancer       Date:  2010-04       Impact factor: 3.869

7.  Endocrine surgical pathology: lesson from pituitary cases that are discordant between clinical and pathologic diagnoses.

Authors:  Toshiaki Sano; Shozo Yamada; Yasunori Ozawa; Akira Shimatsu
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

8.  "Honeycomb Golgi" in pituitary adenomas: not a marker of gonadotroph adenomas.

Authors:  Toshiaki Sano; Rene Mader; Sylvia L Asa; Zhi Rong Qian; Akiko Hino; Shozo Yamada
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

9.  Highly Aggressive and Radiation-Resistant, "Atypical" and Silent Pituitary Corticotrophic Carcinoma: A Case Report and Review of the Literature.

Authors:  Laura Flores; Richard Sleightholm; Beth Neilsen; Michael Baine; Andjela Drincic; William Thorell; Nicole Shonka; David Oupicky; Chi Zhang
Journal:  Case Rep Oncol       Date:  2019-02-08

10.  Cushing Disease After Treatment of Nonfunctional Pituitary Adenoma: A Case Report and Literature Review.

Authors:  Hongjuan Fang; Rui Tian; Huanwen Wu; Jian Xu; Hong Fan; Jian Zhou; Liyong Zhong
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.